Evidence map›Paper›PMID 40574107›Full record

ArticlePharmaceutics2025

Synthesis and In Vitro Evaluation of a Scandium-44 Radiolabeled Nanobody as a PD-L1 PET Imaging Probe.

Viktoria E Krol, Aditya Bansal, Manasa Kethamreddy, Jason R Ellinghuysen, Daniel J Vail, Fabrice Lucien-Matteoni, Haidong Dong, Sean S Park, Mukesh K Pandey

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Application of nanobody‑based CAR‑T in tumor immunotherapy (Review).International journal of molecular medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Viktoria E KrolDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Aditya BansalDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Manasa KethamreddyDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Jason R EllinghuysenDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Daniel J VailDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Fabrice Lucien-MatteoniDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0001-6149-345X
Haidong DongDepartment of Urology, Mayo Clinic, Rochester, MN 55905, USA.
Sean S ParkDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Mukesh K PandeyDepartment of Radiology, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-2332-5305

Funding

Part of the research studies reported in present publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health of the USA (Award Numbers grant UL1TR002494 and UL1TR002377). Additional support wa Award Numbers grant UL1TR002494 and UL1TR002377
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerimmunoPETmolecular imagingPD-L1Scandium-44

Identifiers

PMID40574107
PMCPMC12196724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.